Loading...
XKRX
357780
Market cap1.43bUSD
Dec 05, Last price  
271,500.00KRW
1D
-0.73%
1Q
32.44%
IPO
-3.72%
Name

SoulBrain Co Ltd

Chart & Performance

D1W1MN
XKRX:357780 chart
P/E
17.75
P/S
2.43
EPS
15,295.78
Div Yield, %
Shrs. gr., 5y
-14.42%
Rev. gr., 5y
-3.30%
Revenues
863.36b
+2.29%
775,598,355,835963,424,733,7221,021,271,672,775470,067,532,1311,023,913,370,4551,090,867,446,511844,029,122,450863,356,156,000
Net income
118.44b
-9.15%
41,198,611,03899,548,793,170117,218,710,50163,266,819,770148,517,253,250162,793,517,820130,363,029,221118,437,372,000
CFO
262.35b
+18.68%
112,680,736,851185,742,037,237195,110,976,899138,419,927,306131,901,304,526190,815,190,274221,045,860,070262,345,359,000
Dividend
Dec 27, 20232000 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Soulbrain Co., Ltd. develops, manufactures, and supplies various high tech industry core materials. It provides semiconductor materials, including CVD/ALD materials, etchant and cleaning agents, hydrofluoric acid/buffered oxide etchants for etching and cleaning of semiconductor oxide films, CMP slurries, and plating agents. The company also offers functional chemical materials used in the manufacture of LCD and OLED panels, as well as components of panels, including thin glass and cell scribings. In addition, it provides electronic materials needed for the generation of eco-friendly energy, such as LED process materials, solar cells, and electric vehicle electronic materials. Further, the company offers cosmetics comprising hydrogel mask packs; and develops hospital electronic health record solutions and personal health record platform, as well as body concentration tests and drug-testing products. Additionally, it provides financing, new technology funding, and M&A brokerage and consultancy services; and operates a loan providing financial institution. The company is headquartered in Seongnam-si, South Korea.
IPO date
Aug 06, 2020
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT